March 13, 2026

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

Conexiant

March 11, 2026

Older RSV Hospitalization Linked to Pneumonia

Large Swedish cohort study finds children hospitalized for respiratory syncytial virus at older ages have greater risk of subsequent bacterial pneumonia

Conexiant

March 04, 2026

Pneumonia Patterns Postpandemic

Pneumococcal and RSV RAD-CAP incidence increased as SARS-CoV-2 incidence declined, disproportionately affecting older adults.

Conexiant

March 04, 2026

Albumin Therapy Tested in Septic Shock

Multicenter randomized study finds similar mortality and organ failure outcomes with albumin therapy and standard fluid care

Conexiant

March 02, 2026

Sepsis Antibiotic Timing Shows Physician Divide

Emergency department physicians differ in how quickly they initiate antibiotics for suspected sepsis.

Conexiant

February 16, 2026

Omadacycline for Pediatric CAP

Case details intravenous-to-oral strategy after multiple antibiotic hypersensitivity reactions

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

February 10, 2026

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Conexiant

October 29, 2024

New Data Challenges Pediatric Sinusitis Treatment Guidelines

A JAMA review revealed that only 26% of pediatric ABRS patients treated with placebo required subsequent antibiotic therapy, prompting questions about current guidelines recommending first-line antibiotic use in children with sinusitis.

Conexiant

November 01, 2024

Are Antibiotics Needed for Pediatric Pneumonia?

Nearly one in five children diagnosed with pneumonia in outpatient settings did not receive antibiotics, according to a recent study in JAMA Network Open.

Conexiant